Sian E. Harding

SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

R. Hajjar, S. Harding, T. Thum, 2012, European heart journal.

SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

R. Hajjar, R. Kumarswamy, A. Mills, 2012, European heart journal.

Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis

S. Harding, J. Jacob, L. Castellano, 2015, Cell Death and Disease.